Serina Therapeutics, Inc.
SER- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001708599
In the last 90 days, Serina Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 27 institutions reported holding it in 13F filings for Q2 2026, worth $2.73M in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Serina Therapeutics, Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 25 | 27 | +2 |
| Shares | 1.47M | 1.41M | −65.9K (−4.5%) |
| Value | $2.86M | $2.73M | −$128.5K (−4.5%) |
New holders (5)
Institutions that held Serina Therapeutics, Inc. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Northern Trust Corp | 20,771 | $40.3K | 0.00% |
| Barclays PLC | 545 | $1.06K | 0.00% |
| JPMorgan Chase & Co | 1 | $2 | 0.00% |
| Global Retirement Partners, LLC | 1 | $2 | 0.00% |
| Avion Wealth | 312 | $0 | 0.00% |
Sold out (3)
Institutions that held Serina Therapeutics, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Vanguard Global Advisers, LLC | 368 | $714 |
| Advisory Services Network, LLC | 14 | $27 |
| Federation des caisses Desjardins du Quebec | 1 | $2 |